New Delhi, Feb 8 (UNI) Tata Group patriarch Ratan Tata has invested an undisclosed sum in cancer treatment start up Invictus Oncology Pvt. Ltd. in its series A Funding. Invictus Oncology utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumor, and modulate the tumor immune response. Founded by R A Mashelkar, former Director General, Council of Scientific and Industrial Research, and Shiladitya Sengupta, Harvard Medical School, It is a cancer therapeutics venture. "I have admired Ratan Tata's insights and astute assessment of technology for decades now, I am thrilled he has invested in Invictus, which is not just developing ground-breaking innovations for cancer treatment, but is also among the very first startups based out of India to tread the path of novel discovery and biotech innovation," said Raghunath A Mashelkar, co-founder of Invictus Oncology. Company aims to fight cancer by discovering novel, anti cancer therapeutics right here in India. It believes in the ‘treatment for all’ concept and aim to reach out to cancer patients from all sectors of society with innovative therapies at lower costs, it said in a statement. UNI ABI RN SB 1318